View in EDS HTML Full Text PDF Full Text

Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome.

Saved in:
Bibliographic Details
Title: Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome.
Authors: Premji R; Montage Medical Group, Monterey, California, USA., Nylen ES; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA., Naser N; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA., Gandhi S; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA., Burman KD; Department of Endocrinology, Georgetown University School of Medicine, Washington Hospital Center, Washington, District of Columbia, USA., Sen S; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.
Source: Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2022 Aug; Vol. 20 (6), pp. 321-328. Date of Electronic Publication: 2022 Apr 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101150318 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8518 (Electronic) Linking ISSN: 15404196 NLM ISO Abbreviation: Metab Syndr Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35452324
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Premji+R%22">Premji R</searchLink>; Montage Medical Group, Monterey, California, USA.<br /><searchLink fieldCode="AU" term="%22Nylen+ES%22">Nylen ES</searchLink>; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Naser+N%22">Naser N</searchLink>; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Gandhi+S%22">Gandhi S</searchLink>; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Burman+KD%22">Burman KD</searchLink>; Department of Endocrinology, Georgetown University School of Medicine, Washington Hospital Center, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Sen+S%22">Sen S</searchLink>; Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101150318%22">Metabolic syndrome and related disorders</searchLink> [Metab Syndr Relat Disord] 2022 Aug; Vol. 20 (6), pp. 321-328. <i>Date of Electronic Publication: </i>2022 Apr 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101150318 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-8518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215404196%22">15404196 </searchLink><i>NLM ISO Abbreviation: </i>Metab Syndr Relat Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35452324
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/met.2022.0004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 321
    Titles:
      – TitleFull: Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Premji R
      – PersonEntity:
          Name:
            NameFull: Nylen ES
      – PersonEntity:
          Name:
            NameFull: Naser N
      – PersonEntity:
          Name:
            NameFull: Gandhi S
      – PersonEntity:
          Name:
            NameFull: Burman KD
      – PersonEntity:
          Name:
            NameFull: Sen S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1557-8518
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Metabolic syndrome and related disorders
              Type: main
ResultId 1